Clinical characterization might help in preventing osteonecrosis of the jaw.
Kyrgidis
Athanassios
A
Andreadis
Charalambos
C
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007571:Jaw Diseases / Q000139:chemically induced / Q000517:prevention & control*; D010020:Osteonecrosis / Q000139:chemically induced / Q000517:prevention & control*; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid